Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-26 @ 1:16 AM
NCT ID:
NCT02660034
Group ID:
EG013
Title:
Part B: Dose Expansion Phase - Arm 8
Description:
Participants who were expected to benefit from the combination of a PARP inhibitor and a PD-1 inhibitor received tislelizumab 200 mg IV Q3W + pamiparib 40 mg orally twice daily. This arm included participants with recurrent non-ovarian gynecological cancers (endometrial cancer, cancer of the cervix, and participants with tumors known to be MMR deficient or HRD positive) that were not eligible for inclusion in any other arms of the study. This was an exploratory signal seeking arm.
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
10
Other Number Affected:
5
Other Number At Risk:
10
Study:
NCT02660034
Results Section:
NCT02660034
Adverse Events Module:
NCT02660034